JG
AVXL icon

Jefferies Group’s Anavex Life Sciences AVXL Stock Holding History

Jefferies Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,403
Closed -$35.9K – 1648
2022
Q2 		$34.1K Buy
+3,403
New +$32.2K ﹤0.01% 1424
2022
Q1 		– Sell
-24,470
Closed -$424K – 1532
2021
Q4 		$424K Buy
+24,470
New +$465K ﹤0.01% 1217
2016
Q2 		– Sell
-12,300
Closed -$60K – 2129
2016
Q1 		$60K Buy
+12,300
New +$54.1K ﹤0.01% 2024

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jefferies Group's AVXL Position: Q3 2022 in Review

Jefferies Group sold out of Anavex Life Sciences (AVXL) in Q3 2022, closing a stake of 3,403 shares — an estimated $35.9K sold.

Jefferies Group first reported a position in AVXL in Q1 2016 and held it in 3 quarters. The position peaked at $424K in Q4 2021. 147 funds tracked by Wall St. Rank hold AVXL as of Q3 2022.

  • Jefferies Group reported no remaining Anavex Life Sciences position as of Q3 2022 after selling out during the quarter.
  • Jefferies Group sold 3,403 Anavex Life Sciences shares in Q3 2022, an estimated $35.9K.
  • Jefferies Group first reported a position in Anavex Life Sciences in Q1 2016 and held it in 3 quarters.
  • Jefferies Group's Anavex Life Sciences position peaked at $424K in Q4 2021.
  • 147 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.